Jci_page_head_homepage_01 Jci_page_head_homepage_02
Nichole R. Klatt, Francois Villinger, Pavel Bostik, Shari N. Gordon, Lara Pereira, Jessica C. Engram, Ann Mayne, Richard M. Dunham, Benton Lawson, Sarah J. Ratcliffe, Donald L. Sodora, James Else, Keith Reimann, Silvija I. Staprans, Ashley T. Haase, Jacob D. Estes, Guido Silvestri, Aftab A. Ansari
Published in Volume 118, Issue 6
J Clin Invest. 2008; 118(6):2039–2049 doi:10.1172/JCI33814
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Jci0833814
Figure 7
Longitudinal analysis of the levels of Tregs, activated CD8+ T cells, and SIV-specific CTLs during CD4+ T cell depletion.

(A) Representative flow plot of Tregs gated as CD25hiCD127lo (x axis, CD127; y axis, CD25; previously gated on CD3+CD4+ lymphocytes). Numbers denote percentage of cells within boxed regions. (B) Longitudinal assessment of the percent and absolute number of Tregs in each animal as measured by enumerating CD4+FoxP3+CD25hi T cells and CD4+CD25hiCD127lo T cells through 240 d after depletion. (C) Longitudinal assessment of the number of CD8+Ki67+ T cells in each animal through 240 d after depletion. Vertical lines and tick marks represent CD4-depleting antibody treatment. (D) Percentage of CD8+ T cells producing IFN-γ and TNF-α in response to SIV gag and env peptide pools, as measured by intracellular cytokine staining at –30, 60, and 210 d. Shown are average percent SIV-specific CD8+ T cells and CD8+ T cells that responded to the positive control (Con A). No significant changes in the level of SIV-specific CD8+ T cell responses was observed.